(Q33376149)

English

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression

scientific article

Statements

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression (English)
Arnon Nagler
Andrew Spencer
Jesús San Miguel
Noemi Horvath
Heather J Sutherland
Alexander N Suvorov
Sen H Zhuang
Trilok Parekh
Zhilong Yuan
Wayne Rackoff
Jean-Luc Harousseau
3892-3901

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit